Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Havlin

Showing results (441-450 of 475) with videos related to

Pageof 48
Sort By:
Anti-Cancer Drugs|April 1, 1995
Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic studyK A Havlin, J G Kuhn, J Koeller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2025
Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccineesJan Havlin, Aneta Skotnicova, Eliska Dvorackova, et al.
Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive daysT J O'Rourke, T D Brown, K Havlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2021
Network-based forecasting of climate phenomenaJosef Ludescher, Maria Martin, Niklas Boers, et al.
Anti-Cancer Drugs|April 1, 1994
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 scheduleT D Brown, T J O'Rourke, J G Kuhn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2022
A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shuntMartin Balik, Jan Rulisek, Marek Flaksa, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
New anticancer agentsG R Weiss, C L Arteaga, T D Brown, et al.
Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 28, 2009
pH regulating transporters in neurons from various chemosensitive brainstem regions in neonatal ratsAnna E Kersh, Lynn K Hartzler, Kevin Havlin, et al.
Pageof 48

Showing results (441-450 of 475) with videos related to

Sort By:
Pageof 48
Anti-Cancer Drugs|April 1, 1995
Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic studyK A Havlin, J G Kuhn, J Koeller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2025
Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccineesJan Havlin, Aneta Skotnicova, Eliska Dvorackova, et al.
Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive daysT J O'Rourke, T D Brown, K Havlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2021
Network-based forecasting of climate phenomenaJosef Ludescher, Maria Martin, Niklas Boers, et al.
Anti-Cancer Drugs|April 1, 1994
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 scheduleT D Brown, T J O'Rourke, J G Kuhn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2022
A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shuntMartin Balik, Jan Rulisek, Marek Flaksa, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
New anticancer agentsG R Weiss, C L Arteaga, T D Brown, et al.
Journal of the National Cancer Institute|January 16, 1991
Phase I clinical and pharmacokinetic trial of flavone acetic acidK A Havlin, J G Kuhn, J B Craig, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 28, 2009
pH regulating transporters in neurons from various chemosensitive brainstem regions in neonatal ratsAnna E Kersh, Lynn K Hartzler, Kevin Havlin, et al.
Pageof 48